In support of the Blueprint MedTech Pilot, the POCTRN at CIMIT solicited groundbreaking collaborative research projects in the early stages of translation to improve the diagnosis and treatment of disorders of the nervous system. The solicitation was open from June 1 through June 21. Applications are no longer being accepted.
Awards up to $100K total cost will be made to the most promising and innovative neurotechnologies to help support their development journey toward commercialization.
Awardees will also have the unique opportunity to work directly with mentors experienced in commercializing neurotech devices to help address project related business, regulatory, clinical, and technical issues.
Frequently Asked Questions:
I have heard that this is a “shark tank” approach. Can you explain how that works?
Researchers will present their ideas to a panel of experts in the fields of neuroscience, neurotechnology, engineering, manufacturing, and regulatory affairs. The experts will rapidly evaluate projects during July 2021. The projects with the most potential for success will be communicated to POCTRN leadership and move to a "shark tank" like process for further review and the opportunity to move to the next stage.
Can applicants from outside the U.S. apply?
No. Unfortunately, we are only supporting institutions and organizations based in the United States. Foreign applicants may learn more about future opportunities: NOT-EB-21-018.
What is a pre-proposal?
A pre-proposal is how you indicate your interest in Blueprint MedTech. It serves two purposes: (a) an initial stage of review for applicants to the Pilot program, which will award $100K total cost to successful projects, and (b) as a baseline for NIH to gauge overall interest in the Blueprint MedTech program. It typically takes between one and four hours to submit a pre-proposal. If you’ve read this far, we strongly encourage you to submit one at https://poctrn.org/blueprint-medtech-pilot.
Can I submit an application if I did not submit a pre-proposal?
No. Pre-proposals are required, and late submissions will not be considered. Applications are invitation-only, and only the most promising pre-proposals will be invited to submit. The Pilot program is limited in duration, so we are unable to consider pre-proposals that are not received between June 1 and June 21, 2021.
Will NIH or POCTRN provide summary feedback as to why a proposal was not selected for funding?
Unfortunately, no. NIH and POCTRN are not providing summary feedback to proposals that were not selected for the program. Applicants who were not selected for support are encouraged to consider other NIH and NIBIB funding opportunities.
What is the source of funding for the Blueprint MedTech Pilot?
This effort is supported by the NIH Blueprint for Neuroscience.
How does the Pilot relate to the remainder of the Blueprint MedTech program?
The Pilot is a small-scale, limited duration effort to “seed” the most promising neurotechnologies to prepare a few technology developers for entry into the main program. Additional NIH funding announcements related to the Blueprint MedTech program will be posted here.
How are confidentiality and intellectual property handled?
The information contained within proposals is treated as confidential and all proposal reviewers sign a non-disclosure agreement when accessing the proposals. NIH retains the right to publicly share proposal summaries or abstracts; however, proprietary information will not be shared without the express written consent of the proposal submitter.
Proposals awarded under this solicitation are required to comply with all of the NIH Standard Award Terms and Conditions. Specifically, information on the management of intellectual property can be found in Section 8.2.4 of the NIH Grants Policy Statement. In brief, the Bayh-Dole Act of 1980 (Public Law 96-517; 35 U.S.C. 200-212; Executive Order 12591; 37 C.F.R. 401 et al; updated April 14, 2018.) is applicable to funding recipients and provides incentives to promote the utilization of inventions conceived or reduced to practice in the performance of federally supported research and development. The Bayh-Dole Act also requires that the government be provided a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States any subject invention throughout the world. The Bayh-Dole Act applies to all NIH research and development funding granted to for-profit organizations regardless of size and all non-profit entities.
Where can I get more information about the Pilot?
Information about this project and how to submit a proposal can be found on the POCTRN website.
Still have questions?
Please contact us at Blueprint-MedTech.